Related Experiment Videos
[Basic therapeutic combination therapy in chronic polyarthritis: an overview]
1Rheuma-Zentrum I. Medizinische Klinik, Bad Abbach.
Zeitschrift Fur Rheumatologie
|May 5, 1998
Summary
Combining methotrexate, azathioprine, and chloroquine offers a beneficial triple therapy for rheumatoid arthritis. This approach shows promise for patients with refractory disease when monotherapy is insufficient.
Area of Science:
- Rheumatology
- Clinical Pharmacology
Context:
- Rheumatoid arthritis (RA) management often requires combination therapy for optimal disease control.
- Monotherapy may be insufficient for controlling RA progression and symptoms.
- Various drug combinations have been explored, but study validity is sometimes limited.
Purpose:
- To evaluate the efficacy of a specific triple drug combination for rheumatoid arthritis.
- To present findings from a study involving patients with refractory RA.
Summary:
- A triple combination therapy including methotrexate, azathioprine, and chloroquine was administered to 21 patients with refractory rheumatoid arthritis.
- The study summarized beneficial experiences with this combination regimen.
- This approach aims to improve disease control beyond what is achievable with monotherapy.
Impact:
- Suggests a potentially effective treatment strategy for difficult-to-treat rheumatoid arthritis.
- Highlights the value of combination drug therapy in rheumatology.
- Provides data supporting the use of methotrexate, azathioprine, and chloroquine in combination for RA.